💉 Dutaxel 260 mg Injection | Paclitaxel | Chemotherapy | Oncology | Export Supplier
Dutaxel 260 mg Injection contains Paclitaxel, a chemotherapy agent used in the treatment of various solid tumors. It works by inhibiting cancer cell division through stabilization of microtubules under medical supervision.
🔹 Product Category
Oncology Medicine (Cytotoxic Chemotherapy)
🔹 Composition
Paclitaxel 260 mg
🔹 Indications
✔ Breast Cancer
✔ Ovarian Cancer
✔ Non-Small Cell Lung Cancer (NSCLC)
✔ Kaposi’s Sarcoma
🔹 Key Benefits
✔ Broad-spectrum anti-cancer activity
✔ Effective in multiple solid tumors
✔ Hospital-administered chemotherapy
✔ Clinically established protocol drug
🔹 Dosage & Administration
✔ Intravenous infusion
✔ Administered under oncologist supervision
✔ Dose based on body surface area (BSA)
🔹 Safety & Handling
✔ Cytotoxic drug – special handling required
✔ Administered in controlled clinical settings
✔ Pre-medication often required to reduce reactions
🔹 Packaging
✔ Vial Injection
✔ Export-Ready Packaging Available
✔ Cold-chain / controlled storage supported
✔ Bulk Supply Supported
🔹 Storage
✔ Store as per label instructions
✔ Protect from light
✔ Do not freeze
🔹 Certifications
✔ WHO-GMP Certified
✔ COA & COPP Available
🌍 Target Export Markets & Cities
🇺🇸 USA: New York, Chicago, Houston
🇬🇧 UK: London, Manchester
🇦🇪 UAE: Dubai, Abu Dhabi
🇸🇬 Singapore: Singapore
🇮🇳 India: Mumbai, Delhi, Bangalore
🇵🇭 Philippines: Manila
🇻🇳 Vietnam: Ho Chi Minh City, Hanoi
🇿🇦 South Africa: Johannesburg, Cape Town
🇳🇬 Nigeria: Lagos, Abuja
🇰🇪 Kenya: Nairobi
🇧🇷 Brazil: São Paulo
🇲🇽 Mexico: Mexico City
🇵🇪 Peru: Lima
📍 Location: Nagpur, Maharashtra, India
📦 Product Catalogue Available
✔ Oncology Medicines
✔ Chemotherapy Drugs
✔ Hospital Injectables
✔ Targeted Therapies
📞 Instant Support – Call / WhatsApp Now
📲 +91 8007161282
📲 +91 9970011496
📧 Email
✉️ sales@pacificmedicines.com
